In a report released yesterday, Leah R. Cann from Oppenheimer maintained a Hold rating on Agios Pharma (NASDAQ: AGIO). The company’s shares closed on Friday at $80.68.
Cann wrote:
“Based on the quarterly results and the update provided by Agios’ management, our estimated total product sales and revenue are being adjusted to account for decreased expectations for Idhifa (AG-221). Operating expenses are being modestly adjusted for 2019-2022, primarily to account for slighter lower estimated SG&A. The result is an increased estimated loss per share in 2019, and decreased estimated EPS for 2020-2022.”
According to TipRanks.com, Cann is a 4-star analyst with an average return of 9.0% and a 46.9% success rate. Cann covers the Healthcare sector, focusing on stocks such as Miragen Therapeutics Inc, CytomX Therapeutics Inc, and Crispr Therapeutics AG.
Agios Pharma has an analyst consensus of Strong Buy, with a price target consensus of $89.33.
See today’s analyst top recommended stocks >>
Based on Agios Pharma’s latest earnings release for the quarter ending March 31, the company reported a quarterly GAAP net loss of $90.83 million. In comparison, last year the company had a GAAP net loss of $66.17 million.
Based on the recent corporate insider activity of 59 insiders, corporate insider sentiment is positive on the stock. This means that over the past quarter there has been an increase of insiders buying their shares of AGIO in relation to earlier this year. Most recently, in February 2018, Kaye Foster-Cheek, a Director at AGIO bought 2,200 shares for a total of $104,126.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Agios Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the discovery and development of novel investigational medicines to treat cancer and rare genetic diseases. It focuses on diseases that are directly caused by changes in genes or chromosomes, often passed from one generation to the next.
